Overview

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if using Avonex in combination with Zocor is a safe and effective therapy for subjects with relapsing remitting multiple sclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
Alabama Neurology Associates, PC
Collaborator:
Biogen
Treatments:
Simvastatin